The current state of GPCR-based drug discovery to treat metabolic disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The current state of GPCR-based drug discovery to treat metabolic disease
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-02-03
DOI
10.1111/bph.14157
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of Endogenous (Male) Rodent GLP-1 Secretion and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5
- (2017) Thomas B Farb et al. ENDOCRINOLOGY
- GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy
- (2017) Santhosh Satapati et al. JOURNAL OF LIPID RESEARCH
- Gq and Gs signaling acting in synergy to control GLP-1 secretion
- (2017) Maria Hauge et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The New Biology and Pharmacology of Glucagon
- (2017) T. D. Müller et al. PHYSIOLOGICAL REVIEWS
- The Cardiovascular Biology of Glucagon-like Peptide-1
- (2016) Daniel J. Drucker Cell Metabolism
- Clinical Trials, Triumphs, and Tribulations of Glucagon Receptor Antagonists
- (2016) Mackenzie J. Pearson et al. DIABETES CARE
- The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
- (2016) Varman T. Samuel et al. JOURNAL OF CLINICAL INVESTIGATION
- A comprehensive map of molecular drug targets
- (2016) Rita Santos et al. NATURE REVIEWS DRUG DISCOVERY
- Cherry-picked ligands at histamine receptor subtypes
- (2016) Bassem Sadek et al. NEUROPHARMACOLOGY
- The histaminergic system as a target for the prevention of obesity and metabolic syndrome
- (2016) Gustavo Provensi et al. NEUROPHARMACOLOGY
- Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
- (2016) Peter Kühnen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amylin-mediated control of glycemia, energy balance, and cognition
- (2016) Elizabeth G. Mietlicki-Baase PHYSIOLOGY & BEHAVIOR
- A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis
- (2015) W.-C. Hsiao et al. DIABETES OBESITY & METABOLISM
- GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit
- (2015) A. D. Mancini et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial
- (2015) K. Kaku et al. DIABETES OBESITY & METABOLISM
- GSK256073 acutely regulates NEFA levels via HCA2 agonism but does not achieve durable glycaemic control in type 2 diabetes. A randomised trial
- (2015) Robert Dobbins et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily
- (2015) Bryan L. Roth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RM-493, a Melanocortin-4 Receptor (MC4R) Agonist, Increases Resting Energy Expenditure in Obese Individuals
- (2015) Kong Y. Chen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Discovery of Intestinal Targeted TGR5 Agonists for the Treatment of Type 2 Diabetes
- (2015) Hongliang Duan et al. JOURNAL OF MEDICINAL CHEMISTRY
- G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
- (2015) Kurt Ritter et al. JOURNAL OF MEDICINAL CHEMISTRY
- New genetic loci link adipose and insulin biology to body fat distribution
- (2015) Dmitry Shungin et al. NATURE
- Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
- (2014) David W Dodick et al. LANCET NEUROLOGY
- A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice
- (2014) Da Young Oh et al. NATURE MEDICINE
- Gut Hormone Pharmacology of a Novel GPR119 Agonist (GSK1292263), Metformin, and Sitagliptin in Type 2 Diabetes Mellitus: Results from Two Randomized Studies
- (2014) Derek J. Nunez et al. PLoS One
- Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus
- (2014) Kira B. Harris et al. Therapeutic Advances in Endocrinology and Metabolism
- Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes
- (2013) Nils B. Jørgensen et al. DIABETES
- GPR119 agonists: a promising approach for T2DM treatment? A SWOT analysis of GPR119
- (2013) Sang-Uk Kang DRUG DISCOVERY TODAY
- Cooperation between brain and islet in glucose homeostasis and diabetes
- (2013) Michael W. Schwartz et al. NATURE
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
- (2013) B. Finan et al. Science Translational Medicine
- Diabetes: a 21st century challenge
- (2013) Paul Z Zimmet et al. Lancet Diabetes & Endocrinology
- Effects of JNJ-38431055, a novel GPR119 receptor agonist, in randomized, double-blind, placebo-controlled studies in subjects with type 2 diabetes
- (2012) L. B. Katz et al. DIABETES OBESITY & METABOLISM
- Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice
- (2012) Eric D. Berglund et al. JOURNAL OF CLINICAL INVESTIGATION
- A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents
- (2012) Jian Luo et al. PLoS One
- The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
- (2011) Tingting Li et al. MOLECULAR ENDOCRINOLOGY
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy
- (2009) R Krishna et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
- (2009) R. A. DeFronzo et al. DIABETES CARE
- GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis
- (2009) Hong Lan et al. JOURNAL OF ENDOCRINOLOGY
- Lack of FFAR1/GPR40 Does Not Protect Mice From High-Fat Diet-Induced Metabolic Disease
- (2008) H. Lan et al. DIABETES
- Rational Design of a Combination Medication for the Treatment of Obesity
- (2008) Frank L. Greenway et al. Obesity
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started